Contact
searchSearch
HMP Global
Presentations

An Essential Understanding of Tibial Pedal Physiology and Anatomy

Amputation Prevention Symposium 2020

Stay in the Know

Vascular Disease Management Newsletter

News

Embolization
Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel
07/02/2026
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02,...
07/02/2026
Vascular Disease Management
BTK Treatment for CLTI
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Spur® Peripheral Retrievable Scaffold System in a Select CLTI Cohort
07/02/2026
SAN CLEMENTE, CA — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported...
SAN CLEMENTE, CA — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported...
SAN CLEMENTE, CA — Reflow...
07/02/2026
Vascular Disease Management
Reperfusion Catheters
Now in Europe: RED™ 72 SILVER LABEL
06/30/2026
The RED 72 SILVER LABEL devices are reperfusion catheters designed for acute ischemic stroke. Direct aspiration with RED 72 SILVER LABEL can provide a fast, frontline option for acute ischemic stroke. The COMPASS Trial has shown...
The RED 72 SILVER LABEL devices are reperfusion catheters designed for acute ischemic stroke. Direct aspiration with RED 72 SILVER LABEL can provide a fast, frontline option for acute ischemic stroke. The COMPASS Trial has shown...
The RED 72 SILVER LABEL...
06/30/2026
Vascular Disease Management
Abdominal Aortic Aneurysm
Data Presented on Two-Year Proximal Neck Dynamics From First-in-Human Study of Abdominal Aortic Aneurysm Treatment
06/26/2026
Tempe, AZ – June 25, 2026 – Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its investigational...
Tempe, AZ – June 25, 2026 – Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with pentagalloylglucose (PGG) using its investigational...
Tempe, AZ – June 25, 2026 –...
06/26/2026
Vascular Disease Management
New Guiding Sheath
Volante™ Steerable Guiding Sheath Now Available in US
06/23/2026
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The Volante Steerable Guiding Sheath is designed to facilitate intracardiac, renal and peripheral placement of diagnostic and therapeutic devices.  With five different lengths and six different French sizes,...
Key Highlights  The...
06/23/2026
Vascular Disease Management
Clinical Trials
SYMPHONY-PE Trial Post-Hoc Analysis Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism
06/18/2026
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12 hours of diagnosis may be associated with greater improvement in acute hemodynamic and right ventricle measures compared to treatment after 12 hours, with similar safety outcomes between groups.
Treating patients within 12...
06/18/2026
Cath Lab Digest
Team Communication
IB Nimble 2 Adds In-App DICOM Viewing for Real-Time Multidisciplinary Collaboration
06/17/2026
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is the ability to view medical images directly within the app. This long-awaited feature enables care teams to review imaging in real time.
The most notable enhancement is...
06/17/2026
Cath Lab Digest
CE Mark
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
06/16/2026
The THUNDERBOLT™ Computer Assisted Vacuum Thrombectomy (CAVT™) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal.
The THUNDERBOLT™ Computer Assisted Vacuum Thrombectomy (CAVT™) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal.
The THUNDERBOLT™ Computer...
06/16/2026
Cath Lab Digest
FDA Clearance
Penumbra’s THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
06/15/2026
Powered by the Penumbra ENGINE™, THUNDERBOLT introduces modulated aspiration to Penumbra’s neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion. 
Powered by the Penumbra ENGINE™, THUNDERBOLT introduces modulated aspiration to Penumbra’s neuro thrombectomy portfolio, offering advanced CAVT technology designed to detect, fatigue, and completely ingest clot at the site of the occlusion. 
Powered by the Penumbra ENGINE™,...
06/15/2026
Cath Lab Digest
Veterans With PAD
Department of Veteran Affairs Referrals for Peripheral Artery Disease Nearly Triples Over the Past Five Years
06/15/2026
More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals.
More than 180,000 veterans receive care for PAD in Department of Veterans Affairs hospitals.
More than 180,000 veterans...
06/15/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use